Cargando…

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson’s Disease

BACKGROUND: Parkinson’s disease (PD) patients are affected by hypokinetic dysarthria, characterized by hypophonia and dysprosody, which worsens with disease progression. Levodopa’s (l-dopa) effect on quality of speech is inconclusive; no data are currently available for late-stage PD (LSPD). OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabbri, Margherita, Guimarães, Isabel, Cardoso, Rita, Coelho, Miguel, Guedes, Leonor Correia, Rosa, Mario M., Godinho, Catarina, Abreu, Daisy, Gonçalves, Nilza, Antonini, Angelo, Ferreira, Joaquim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572389/ https://www.ncbi.nlm.nih.gov/pubmed/28878734 http://dx.doi.org/10.3389/fneur.2017.00432

Ejemplares similares

High frequency of psychosis in late-stage Parkinsońs disease
por: Chendo, Inês, et al.
Publicado: (2021)

Profile of cognitive impairment in late‐stage Parkinson's disease
por: Severiano e Sousa, Catarina, et al.
Publicado: (2022)

Clinical Diagnostic Criteria Have a High Impact on the Frequency of Dementia in Late-Stage Parkinson's Disease
por: Severiano e Sousa, Catarina, et al.
Publicado: (2021)

Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
por: Ferreira, Joaquim J., et al.
Publicado: (2022)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Personalized Care in Late-Stage Parkinson’s Disease: Challenges and Opportunities
por: Fabbri, Margherita, et al.
Publicado: (2022)

Speech and Voice
Publicado: (1943)

Voice and speech in the theatre
por: Turner, J. Clifford (James Clifford)
Publicado: (1950)

Physiology of Voice and Speech
Publicado: (1867)

Speech and Voice Correction
Publicado: (1948)

The Pathology of Speech and Voice
por: Guthrie, Douglas
Publicado: (1940)

Voice, Song and Speech
Publicado: (1885)

Clinical trials in palliative care: a systematic review of their methodological characteristics and of the quality of their reporting
por: Bouça-Machado, Raquel, et al.
Publicado: (2017)

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
por: Oliveira, Sara R., et al.
Publicado: (2020)

Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa
por: Zadikoff, Cindy, et al.
Publicado: (2020)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
por: Poewe, Werner, et al.
Publicado: (2010)

How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety
por: Poewe, Werner, et al.
Publicado: (2019)

Levodopa–carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry
por: Poewe, Werner, et al.
Publicado: (2019)

Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry
por: Poewe, Werner, et al.
Publicado: (2020)

Levodopa-Based Changes on Vocalic Speech Movements during Prosodic Prominence Marking
por: Thies, Tabea, et al.
Publicado: (2021)

Levodopa-Induced Pseudopheochromocytoma
por: Cardoso, Joana, et al.
Publicado: (2023)

Voice and Speech Quality Perception: Assessment and Evaluation
por: Jekosch, Ute
Publicado: (2005)

Voice Quality Modelling for Expressive Speech Synthesis
por: Monzo, Carlos, et al.
Publicado: (2014)

Beyond speech: Exploring diversity in the human voice
por: Anikin, Andrey, et al.
Publicado: (2023)

The Temporal Voice Areas are not “just” Speech Areas
por: Trapeau, Régis, et al.
Publicado: (2023)

Effect of levodopa‐carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
por: Antonini, Angelo, et al.
Publicado: (2016)

Integrating Voice Quality Cues in the Pitch Perception of Speech and Non-speech Utterances
por: Kuang, Jianjing, et al.
Publicado: (2018)

A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy
por: Simões, Rita Moiron, et al.
Publicado: (2020)

Patients and Health Professional's Perspective of Functional Mobility in Parkinson's Disease
por: Bouça-Machado, Raquel, et al.
Publicado: (2020)

Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
por: Ferreira, Joaquim J., et al.
Publicado: (2022)

The art and business of speech recognition: creating the noble voice
por: Kotelly, Blade
Publicado: (2003)

A Novel Voice Sensor for the Detection of Speech Signals
por: Wang, Kun-Ching
Publicado: (2013)

Does the wearing of masks change voice and speech parameters?
por: Gama, R., et al.
Publicado: (2021)

Convergence in voice fundamental frequency during synchronous speech
por: Bradshaw, Abigail R., et al.
Publicado: (2021)

Continuous Speech for Improved Learning Pathological Voice Disorders
Publicado: (2022)

Acoustic Measurements of Speech and Voice in Men with Angle Class II, Division 1, Malocclusion
por: Viegas, Flávia, et al.
Publicado: (2022)

Levodopa Effects on Hand and Speech Movements in Patients with Parkinson’s Disease: A fMRI Study
por: Maillet, Audrey, et al.
Publicado: (2012)

Slurring of Speech and Lip Paresthesia: Symptoms of Levodopa End of Dose Wearing Off in Parkinson's Disease
por: Nasir, Usama, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5rqtd0ust69737e7f541svojj7